Murayama N - Search Results

1

Missense and nonsense mutations of the flavin-containing monooxygenase 3 gene in a Japanese cohort.

Shimizu M, Tomioka S, Murayama N, Yamazaki H. Shimizu M, et al. Among authors: murayama n. Drug Metab Pharmacokinet. 2007 Feb 25;22(1):61-4. doi: 10.2133/dmpk.22.61. Drug Metab Pharmacokinet. 2007. PMID: 17329912 Free article.

2

Metabolic activation of o-phenylphenol to a major cytotoxic metabolite, phenylhydroquinone: role of human CYP1A2 and rat CYP2C11/CYP2E1.

Ozawa S, Ohta K, Miyajima A, Kurebayashi H, Sunouchi M, Shimizu M, Murayama N, Matsumoto Y, Fukuoka M, Ohno Y. Ozawa S, et al. Among authors: murayama n. Xenobiotica. 2000 Oct;30(10):1005-17. doi: 10.1080/00498250050200159. Xenobiotica. 2000. PMID: 11315102

3

CYP3A4 gene polymorphisms influence testosterone 6beta-hydroxylation.

Murayama N, Nakamura T, Saeki M, Soyama A, Saito Y, Sai K, Ishida S, Nakajima O, Itoda M, Ohno Y, Ozawa S, Sawada J. Murayama N, et al. Drug Metab Pharmacokinet. 2002;17(2):150-6. doi: 10.2133/dmpk.17.150. Drug Metab Pharmacokinet. 2002. PMID: 15618664 Free article.

4

Rat cytochrome P450 2C11 in liver microsomes involved in oxidation of anesthetic agent propofol and deactivated by prior treatment with propofol.

Yamazaki H, Shimizu M, Nagashima T, Minoshima M, Murayama N. Yamazaki H, et al. Among authors: murayama n. Drug Metab Dispos. 2006 Nov;34(11):1803-5. doi: 10.1124/dmd.106.011627. Epub 2006 Aug 8. Drug Metab Dispos. 2006. PMID: 16896062

5

Effect of genetic variants of the human flavin-containing monooxygenase 3 on N- and S-oxygenation activities.

Shimizu M, Yano H, Nagashima S, Murayama N, Zhang J, Cashman JR, Yamazaki H. Shimizu M, et al. Among authors: murayama n. Drug Metab Dispos. 2007 Mar;35(3):328-30. doi: 10.1124/dmd.106.013094. Epub 2006 Dec 1. Drug Metab Dispos. 2007. PMID: 17142560

6

Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.

Shimada T, Murayama N, Okada K, Funae Y, Yamazaki H, Guengerich FP. Shimada T, et al. Among authors: murayama n. Chem Res Toxicol. 2007 Mar;20(3):489-96. doi: 10.1021/tx600299p. Epub 2007 Feb 10. Chem Res Toxicol. 2007. PMID: 17291012

7

Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.

Murayama N, Imai N, Nakane T, Shimizu M, Yamazaki H. Murayama N, et al. Biochem Pharmacol. 2007 Jun 15;73(12):2020-6. doi: 10.1016/j.bcp.2007.03.012. Epub 2007 Mar 19. Biochem Pharmacol. 2007. PMID: 17433262

8

Involvement of human cytochrome P450 2B6 in the omega- and 4-hydroxylation of the anesthetic agent propofol.

Murayama N, Minoshima M, Shimizu M, Guengerich FP, Yamazaki H. Murayama N, et al. Xenobiotica. 2007 Jul;37(7):717-24. doi: 10.1080/00498250701449431. Xenobiotica. 2007. PMID: 17620218

9

Comparison of kinetic parameters for drug oxidation rates and substrate inhibition potential mediated by cytochrome P450 3A4 and 3A5.

Niwa T, Murayama N, Emoto C, Yamazaki H. Niwa T, et al. Among authors: murayama n. Curr Drug Metab. 2008 Jan;9(1):20-33. doi: 10.2174/138920008783331121. Curr Drug Metab. 2008. PMID: 18220568 Review.

10

Complex mechanism underlying transcriptional control of the haplotyped flavin-containing monooxygenase 3 (FMO3) gene in Japanese: different regulation between mutations in 5'-upstream distal region and common element in proximal region.

Shimizu M, Murayama N, Nagashima S, Fujieda M, Yamazaki H. Shimizu M, et al. Among authors: murayama n. Drug Metab Pharmacokinet. 2008;23(1):54-8. doi: 10.2133/dmpk.23.54. Drug Metab Pharmacokinet. 2008. PMID: 18305374 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

651 results

Search Page

Filters